Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of Tuberculosis, Ho Chi Minh City, Vietnam, 2020–2023
Ruan Spies
, Hanh N. Hong, Phu P. Trieu, Luong K. Lan, Kim Lan, N.N. Hue, Nguyen T.L. Huong, Tran T.L.N. Thao, Nguyen L. Quang, Thu D.D. Anh, Truong V. Vinh, Dang T.M. Ha, Phan T. Dat, Nguyen P. Hai, Le H. Van, Guy E. Thwaites, Nguyen T.T. Thuong, James A. Watson
1, and Timothy M. Walker
1
Author affiliations: University of Oxford, Oxford, UK (R. Spies, G.E. Thwaites, N.T.T. Thuong, J.A. Watson, T.M. Walker); Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam (H.N. Hong, P.P. Trieu, L.K. Lan, K. Lan, N.N. Hue, N.T.L. Huong, T.L.T.N. Thao, N.L. Quang, T.D.D. Anh, L.H. Van, G.E. Thwaites, N.T.T. Thuong, J.A. Watson, T.M. Walker); Pham Ngoc Thach Hospital, Ho Chi Minh City (T.V. Vinh, D.T.M. Ha, P.T. Dat, N.P. Hai)
Main Article
Figure 1
Figure 1. Population pyramids of age and sex distributions of participants registered for TB treatment in Ho Chi Minh City, Vietnam, January 1, 2020–April 30, 2023. A) DS TB; B) MDR TB. DS, drug-susceptible; MDR, multidrug-resistant; TB, tuberculosis.
Main Article
Page created: December 10, 2023
Page updated: February 22, 2024
Page reviewed: February 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.